Monday, June 15, 2026

Chong Kun Dang Wins European Phase 1 Approval for Dupixent Biosimilar: Advancing CKD-706’s Global Development

Chong Kun Dang's CKD-706 biosimilar for Dupixent received Phase 1 trial approval in Europe, aiming to expand treatment options for inflammatory diseases.

North Korea Warns of Retaliation Over U.S.-Led Multinational Naval Drills

North Korea warns of retaliation against recent multinational maritime exercises led by the U.S. in the South Pacific.

Is North Korea Ready for Tourism? China’s Travel Agencies Launch Group Tours Amid Uncertainty

North Korea and China resume passenger train services, with Chinese travel agencies launching group tours to North Korea.

Tag: bio-oil

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.